Editor’s highlights from Future Oncology – September 2020
Oncology Central,
In this latest instalment of his regular monthly column, Louis Gautier, Commissioning Editor of Future Oncology, exclusively…
In this latest instalment of his regular monthly column, Louis Gautier, Commissioning Editor of Future Oncology, exclusively…
The FDA has approved the first drug ever for the rare skin cancer, Merkel cell carcinoma, and updated data show an improved…
In a phase II clinical trial, some patients with metastatic Merkel cell carcinoma whose cancer has progressed despite treatment…